ahlam1399
03-01-2016, 11:01 PM
BRIEF-Gilead Sciences says U.S. FDA approves Odefsey
* U.S. Food And Drug Administration Approves Gilead's Second Taf-Based single tablet regimen odefsey (emtricitabine, rilpivirine, te**fovir alafenamide) for the treatment of HIV-1 infection
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4df626af/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=ZNRFaV27z20:ZSBBZL2aYWo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ZNRFaV27z20:ZSBBZL2aYWo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=ZNRFaV27z20:ZSBBZL2aYWo:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ZNRFaV27z20:ZSBBZL2aYWo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=ZNRFaV27z20:ZSBBZL2aYWo:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/ZNRFaV27z20
* U.S. Food And Drug Administration Approves Gilead's Second Taf-Based single tablet regimen odefsey (emtricitabine, rilpivirine, te**fovir alafenamide) for the treatment of HIV-1 infection
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4df626af/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=ZNRFaV27z20:ZSBBZL2aYWo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ZNRFaV27z20:ZSBBZL2aYWo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=ZNRFaV27z20:ZSBBZL2aYWo:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ZNRFaV27z20:ZSBBZL2aYWo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=ZNRFaV27z20:ZSBBZL2aYWo:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/ZNRFaV27z20